Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2007 1
2009 1
2011 1
2014 1
2015 1
2016 1
2019 1
2020 2
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Common Variant Anaplastic Large Cell Lymphoma"
Page 1
Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma.
Zic JA. Zic JA. Med Clin North Am. 2021 Jul;105(4):737-755. doi: 10.1016/j.mcna.2021.04.010. Med Clin North Am. 2021. PMID: 34059248 Review.
The cutaneous T-cell lymphomas include variants that can mimic the presentation of common skin diseases or arthropod bites. Mycosis fungoides, the most common cutaneous T-cell lymphoma, usually presents as fixed asymptomatic patches or pl …
The cutaneous T-cell lymphomas include variants that can mimic the presentation of common skin diseases or arthropod bi …
Cutaneous lymphoproliferative disorders in organ transplant recipients: update 2014.
Seçkin D. Seçkin D. G Ital Dermatol Venereol. 2014 Aug;149(4):401-8. G Ital Dermatol Venereol. 2014. PMID: 25068227 Review.
A recent multicenter European case series showed that primary cutaneous T-cell PTLD are more common than primary cutaneous B-cell PTLD, and along with its folliculotropic variant, mycosis fungoides (MF) is the most frequent form of posttransplant prima …
A recent multicenter European case series showed that primary cutaneous T-cell PTLD are more common than primary cutaneous B- …
Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.
Laurent C, Do C, Gascoyne RD, Lamant L, Ysebaert L, Laurent G, Delsol G, Brousset P. Laurent C, et al. J Clin Oncol. 2009 Sep 1;27(25):4211-6. doi: 10.1200/JCO.2008.21.5020. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19636007
PURPOSE: Anaplastic lymphoma kinase (ALK) -positive diffuse large B-cell lymphoma (DLBCL) is a rare variant of DLBCL that has been described only in small case reports. To shed more light on the clinical and pathologic features and …
PURPOSE: Anaplastic lymphoma kinase (ALK) -positive diffuse large B-cell lymphoma (DLBCL) is a rare va …
Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma.
Yamashita T, Higashi M, Momose S, Adachi A, Watanabe T, Tanaka Y, Tokuhira M, Kizaki M, Tamaru JI. Yamashita T, et al. Sci Rep. 2020 Jun 25;10(1):10391. doi: 10.1038/s41598-020-67500-w. Sci Rep. 2020. PMID: 32587329 Free PMC article.
Recently, it has been reported that MYC regulates the proliferation of anaplastic large cell lymphoma. However, the expression and function of MAX in anaplastic large cell lymphoma remain to be elucidated. We herein investig …
Recently, it has been reported that MYC regulates the proliferation of anaplastic large cell lymphoma. However, …
Primary brain CD30+ ALK1+ anaplastic large cell lymphoma ('ALKoma'): the first case with a combination of 'not common' variants.
Ponzoni M, Terreni MR, Ciceri F, Ferreri AJ, Gerevini S, Anzalone N, Valle M, Pizzolito S, Arrigoni G. Ponzoni M, et al. Ann Oncol. 2002 Nov;13(11):1827-32. doi: 10.1093/annonc/mdf300. Ann Oncol. 2002. PMID: 12419758 Free article. Review.
BACKGROUND: Primary central nervous system lymphomas (PCNSLs) are rare tumors, mostly represented by diffuse large B cells. PCNSLs with a T phenotype are less frequently reported; even rarer are anaplastic large cell lymphomas (ALCLs). ...Patient and m …
BACKGROUND: Primary central nervous system lymphomas (PCNSLs) are rare tumors, mostly represented by diffuse large B cells. PCNSLs wi …
Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.
Tabanelli V, Corsini C, Fiori S, Agostinelli C, Calleri A, Orecchioni S, Melle F, Motta G, Rotili A, Di Napoli A, Pileri SA. Tabanelli V, et al. Hum Pathol. 2019 Aug;90:60-69. doi: 10.1016/j.humpath.2019.05.007. Epub 2019 May 21. Hum Pathol. 2019. PMID: 31125630
Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a variant of anaplastic large cell lymphoma arising within seroma effusion associated with breast implants. ...We report frequent PDL1 expression a …
Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a variant of anaplastic l …
Sarcomatoid variant of anaplastic large cell lymphoma mimicking a primary breast cancer: a challenging diagnosis.
Pereira EM, Maeda SA, Reis-Filho JS. Pereira EM, et al. Arch Pathol Lab Med. 2002 Jun;126(6):723-6. doi: 10.5858/2002-126-0723-SVOALC. Arch Pathol Lab Med. 2002. PMID: 12033965 Free article.
The sarcomatoid variant of anaplastic large cell lymphoma is one of the rarest histologic variants of this neoplasm. ...To the best of our knowledge, this is the first reported case of sarcomatoid anaplastic large cell …
The sarcomatoid variant of anaplastic large cell lymphoma is one of the rarest histologic variants …
Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.
Boddicker RL, Razidlo GL, Dasari S, Zeng Y, Hu G, Knudson RA, Greipp PT, Davila JI, Johnson SH, Porcher JC, Smadbeck JB, Eckloff BW, Billadeau DD, Kurtin PJ, McNiven MA, Link BK, Ansell SM, Cerhan JR, Asmann YW, Vasmatzis G, Feldman AL. Boddicker RL, et al. Blood. 2016 Sep 1;128(9):1234-45. doi: 10.1182/blood-2016-03-707141. Epub 2016 Jun 13. Blood. 2016. PMID: 27297792 Free PMC article. Clinical Trial.
Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous group of T-cell malignancies that generally demonstrate aggressive clinical behavior, often are refractory to standard therapy, and remain significantly understudied. ...These were observed exclusi …
Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous group of T-cell malignancies that generally demonstrate aggressi …
Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature.
Grewal JS, Smith LB, Winegarden JD 3rd, Krauss JC, Tworek JA, Schnitzer B. Grewal JS, et al. Ann Hematol. 2007 Jul;86(7):499-508. doi: 10.1007/s00277-007-0289-3. Epub 2007 Mar 30. Ann Hematol. 2007. PMID: 17396261 Review.
Anaplastic large cell lymphoma (ALCL) is an aggressive neoplasm of T- or null cell phenotype and is recognized as a distinct clinicopathologic subtype of non-Hodgkin lymphoma (NHL) in the revised World Health Organization (WHO) classifica …
Anaplastic large cell lymphoma (ALCL) is an aggressive neoplasm of T- or null cell phenotype and is recog …
ALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitors.
Lovisa F, Cozza G, Cristiani A, Cuzzolin A, Albiero A, Mussolin L, Pillon M, Moro S, Basso G, Rosolen A, Bonvini P. Lovisa F, et al. PLoS One. 2015 Apr 13;10(4):e0121378. doi: 10.1371/journal.pone.0121378. eCollection 2015. PLoS One. 2015. PMID: 25874976 Free PMC article.
ALK inhibitor crizotinib has shown potent antitumor activity in children with refractory Anaplastic Large Cell Lymphoma (ALCL) and the opportunity to include ALK inhibitors in first-line therapies is oncoming. ...Amplicon ultra-deep sequencing of ALK k …
ALK inhibitor crizotinib has shown potent antitumor activity in children with refractory Anaplastic Large Cell Lymph …
13 results